| Identify the most common pediatric brain tumors, their clinical manifestations and genetic causes. |
|
|
|
|
|
|
| Explain the difference in chemotherapy, radiation therapy and immunotherapy for pediatric brain tumors. |
|
|
|
|
|
|
| Explain the biology, rationale and pre-clinical development of chimeric antigen receptors (CAR T) cells. |
|
|
|
|
|
|
| Explain how nutrients can work at different levels of carcinogenesis to decrease risk of cancer. |
|
|
|
|
|
|
| Implement a nutrition plan as a part of a comprehensive cancer treatment plan. |
|
|
|
|
|
|
| Implement immunotherapy into the management of high-risk patients with neuroblastoma. |
|
|
|
|
|
|
| Identify when to initiate legal action in the clinical decision making process for a pediatric patient. |
|
|
|
|
|
|
| Analyze the relationship between genomics and pediatric malignancies. |
|
|
|
|
|
|
| Explain the contribution of genomics to improving cancer survival. |
|
|
|
|
|
|
| Explain appropriate implementation of proton therapy. |
|
|
|
|
|
|
| Discuss the incidence of specific late adverse effects on children treated with radiation therapy. |
|
|
|
|
|
|
| Examine the dosimetric and clinical evidence supporting the use of proton therapy in children. |
|
|
|
|
|
|
| Identify pediatric-specific immunotherapies that are both approved and in clinical trials. |
|
|
|
|
|
|
| Initiate appropriate treatment referrals for children diagnosed with acute leukemias. |
|
|
|
|
|
|
| Implement necessary treatment plans to improve patient outcomes. |
|
|
|
|
|
|
| Identify the neurocognitive sequela of kids with cancer. |
|
|
|
|
|
|
| Identify the early signs of neurocognitive decline to promote timely referrals for appropriate interventions. |
|
|
|
|
|
|
| Explain the future direction in pediatric oncology. |
|
|
|
|
|
|
| Explain the benefits of receiving pediatric radiation therapy at a high volume center specializing in treating children. |
|
|
|
|
|
|
| Identify the various types of tumors seen in NF and implement management plans. |
|
|
|
|
|
|
| Analyze challenging cases in pediatric cancers and implement appropriate treatment options. |
|
|
|
|
|
|
